The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Dr Greg Carder, LDN Radio Show 28 June 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Greg Carder shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Dr Bruce Berman, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: I'm joined today by Dr Bruce Berman from sunny Florida in the US thanks for joining me, Bruce.
Dr Bruce Berman: My pleasure.
Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy
Int Immunopharmacol
11 May 2021
https://pubmed.ncbi.nlm.nih.gov/33989971/
Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and Beta-Endorphin
eNeuro
24 May 2021
https://www.eneuro.org/content/early/2021/05/21/ENEURO.0087-21.2021
Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats
Psychopharmacology (Berl)
November 2014
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209193/
Antagonising TLR4-TRIF signalling before or after a low-dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood
Neuropharmacology
January 2018
https://pubmed.ncbi.nlm.nih.gov/28947376/
Co-Administration of Low-Dose Naltrexone and Bupropion Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats
Alcohol Clin Exp Res
March 2018
https://pubmed.ncbi.nlm.nih.gov/29222923/
Background: This study examined whether combining naltrexone (NTX) with bupropion (BUP) is more effective in reducing alcohol drinking in alcohol-preferring (P) rats with a genetic predisposition toward high voluntary alcohol intake than either drug alone.
Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study
J Addict Med
June 2018
https://pubmed.ncbi.nlm.nih.gov/29438157/
Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice
Alcohol Clin Exp Res
June 2019
https://pubmed.ncbi.nlm.nih.gov/30908671/